Generic drug manufacturers in our country point out that the introduction of treatments on the compensation list occurs with ...

When Joani Reisen said her health insurance suddenly cut off coverage for her critical medication, she turned to an unlikely ...

The real question is how to re-shore pharmaceutical production while minimizing the costs to patients, economist Tomas J.

There is an urgent need for low- and middle-income countries to ensure equitable, affordable, and sustained access to tobacco-cessation medications at scale.

On top of that, drug ads must provide “fair balance,” meaning the positives and negatives have to both be presented. In ...

The Trump administration believes — correctly — that the existing prescription drug supply chain endangers our national ...

One of the great triumphs of health policy is America’s generic drug market. Nine out of ten U.S. prescriptions are filled with generics. That overwhelming share saves patients and taxpayers hundreds ...

The problem America faces is that U.S. patients are now dangerously dependent on foreign suppliers. China controls up to 90% ...

A generic formulation of Zeposia will be manufactured and supplied by Netherlands-based Synthon, upon final approval by the ...

The settlement agreement will extend market exclusivity for AbbVie's JAK inhibitor in the U.S. until 2037—providing pediatric exclusivity is granted.

Virginia has outpaced the national average in Medicaid spending, an analysis of data by groups of pharmacists found. The ...